Southbreeze: For you to dismiss dilution as a leg
Post# of 30028
Posted On: 09/13/2014 1:00:35 PM
Re: SouthBreeze #6207
Southbreeze: For you to dismiss dilution as a legitimate concern for AMBS shareholders is incredibly naive! We are a small bio-med penny stock. Did you not know that dilution was one of the major dangers facing the shareholders of such stocks? To think AMBS is shielded from this danger is plain ignorant.
The same things Gerald is saying about why we need this second billion shares (Hostile take overs, acquisitions, spin offs, etc) are all things he said when he raised the authorized shares to one billion in 2013. What percentage of the dilution we've experienced over the past 18 months has gone for those issues and what percentage has gone to simply fund the company? That's a legitimate point to be considered.
Some say dilution is just a fact of life for small penny stock biomeds. Yes, "some" dilution is. It is the responsibility of shareholders to keep a watchful eye on management and question them when dilution flags are appearing. Some here on this board have drunk so much AMBS Kool Aid that to question management is akin to blasphemy! Honestly, this mb has become almost like a religious cult to the point where if someone dares to question the company.....the board pounces on them.
I pounce on obvious bashers all the time! So what goes around comes around. I get it. But I'm no obvious basher, I'm an obvious long. For others on the mb not to realize that and think I am "soft bashing" shows they are severely lacking in perception and critical thinking.
Management doesn't worry about dilution in the same way shareholders do. My family's 1.1 million shares represents hard earned money. Management has millions of shares given to them as part of their compensation package. When someone owns 6 million shares instead of 500,000 shares, dilution doesn't really matter as much because no matter how much dilution there is....as long as the stock does reasonable well, they will still be worth multiple millions! Not so for the little guy.
I am a long. I believe in AMBS science. I am first about LymPro revenue, second about MANF's endless potential down the road, and third....I believe everything else is gravy. (Eltoprazine & Phenoguard). I'm no biotech expert, (and neither is the guy with that alias) but I've been around the small bio med business long enough to know 3 things:
1) Biotech Management has to engage in "sausage" making. (What goes on behind the scenes is not something shareholders would be happy about if they fully knew) This is just reality. Most small bio-techs don't realize their dreams, neither do most new drugs.
2) Biotechs Dilute to Keep their Dreams Alive. They have to. Big Pharma don't treat them kindly or try to help them out.....BP hopes AMBS fails.
3) Some Small Biotechs Make it Incredibly Big!! But those who do are a relatively small percentage of the total.
These 3 things I've learned have made me question every stock I'm in. I don't view management as though they were God's representatives. To be safe, I view them as God's competitor's representatives. This is not personal, it's just business. IMHO, when shareholders stop questioning management because they are in love with the dream management has created about how how rich they'll all become....that is when really bad things can happen to shareholders.
This mb would be better served if it were more tolerant of questions about what management is doing rather than 95% of all posts being about how wonderful MANF is!!!!!!! We get it. MANF is wonderful. But what if we only posted that 50% of the time, and the other 50% we discussed legitimate concerns? Not concerns raised by obvious bashers and flippers like Solantey and such, but coming from legitimate longs.
I think Gerald and management need to hear from shareholders about their real concerns. The Shareholder Meeting would be a good place for voicing some of those honest concerns. Unlike Warp, I thought the gentleman who pressed Gerald on those 5 questions during the CC was right on!! Warp writes off discussion about concerns as anxious "hand wringing" and the cause of "sleepless nights" that only the poor engage in, who really shouldn't be invested in this type of stock in the first place. I thought the gentleman asking the questions on the CC was respectful, but earnest. Sending Gerald messages all the time about how much we all admire him is not what he really needs. He's the CEO managing our investment. He needs to hear from us. We need to discuss issues seriously...not just dream of how rich we'll be.
Gerald needs to know that his credibility is on the line over the way he has mismanaged expectations. At the Jan. Conference in SF he said we wouldn't be pursuing a LymPro partner in the immediate future because of the "codes" they found that had increased the Net Present Value of LymPro multiple times! We haven't really heard about those "codes" since and we are trading at less than we were in January when he announced it!
Several months after January Gerald stated they had "identified" a LymPro Partner which would be announced at the end of summer. I think most of us anticipated it would be a "classic partner" with up front money. So when he tweeted that Friday afternoon about how excited he was over the news the next week....it was a real shock that Monday morning when we got a "master service agreement" with ICON rather than a "Classic Partnership" with J&J with 40 million dollars up front!!! These two examples I've mentioned, along with the data debacle during the July Conferences are examples of how Gerald has not managed expectations or executed flawlessly. (Not that I want him replaced)
At the beginning of the year his goal was to up list in Q2 of 2014. Now we are hearing Q1 2015. People have criticized me for worrying too much about the short term pps. They think I need reminding that this is a long term investment. I get it. All I am saying is that until more shareholder value is created....management should no leverage our shares with a billion additional shares! There's no good reason for doing a billion shares now, not when we're trading at .10 cents in mid September.
To not discuss these concerns on this mb and not raise them with management, but simply let them double the AS shares without even a peep from us.....is nothing more than Kool Aid drinking insecurity!!
I hope as participants in this mb we can mature into something more. We are the owners of AMBS and we need to intelligently raise our voice to management on an ongoing basis, so that together we can realize the incredible potential AMBS has!
The same things Gerald is saying about why we need this second billion shares (Hostile take overs, acquisitions, spin offs, etc) are all things he said when he raised the authorized shares to one billion in 2013. What percentage of the dilution we've experienced over the past 18 months has gone for those issues and what percentage has gone to simply fund the company? That's a legitimate point to be considered.
Some say dilution is just a fact of life for small penny stock biomeds. Yes, "some" dilution is. It is the responsibility of shareholders to keep a watchful eye on management and question them when dilution flags are appearing. Some here on this board have drunk so much AMBS Kool Aid that to question management is akin to blasphemy! Honestly, this mb has become almost like a religious cult to the point where if someone dares to question the company.....the board pounces on them.
I pounce on obvious bashers all the time! So what goes around comes around. I get it. But I'm no obvious basher, I'm an obvious long. For others on the mb not to realize that and think I am "soft bashing" shows they are severely lacking in perception and critical thinking.
Management doesn't worry about dilution in the same way shareholders do. My family's 1.1 million shares represents hard earned money. Management has millions of shares given to them as part of their compensation package. When someone owns 6 million shares instead of 500,000 shares, dilution doesn't really matter as much because no matter how much dilution there is....as long as the stock does reasonable well, they will still be worth multiple millions! Not so for the little guy.
I am a long. I believe in AMBS science. I am first about LymPro revenue, second about MANF's endless potential down the road, and third....I believe everything else is gravy. (Eltoprazine & Phenoguard). I'm no biotech expert, (and neither is the guy with that alias) but I've been around the small bio med business long enough to know 3 things:
1) Biotech Management has to engage in "sausage" making. (What goes on behind the scenes is not something shareholders would be happy about if they fully knew) This is just reality. Most small bio-techs don't realize their dreams, neither do most new drugs.
2) Biotechs Dilute to Keep their Dreams Alive. They have to. Big Pharma don't treat them kindly or try to help them out.....BP hopes AMBS fails.
3) Some Small Biotechs Make it Incredibly Big!! But those who do are a relatively small percentage of the total.
These 3 things I've learned have made me question every stock I'm in. I don't view management as though they were God's representatives. To be safe, I view them as God's competitor's representatives. This is not personal, it's just business. IMHO, when shareholders stop questioning management because they are in love with the dream management has created about how how rich they'll all become....that is when really bad things can happen to shareholders.
This mb would be better served if it were more tolerant of questions about what management is doing rather than 95% of all posts being about how wonderful MANF is!!!!!!! We get it. MANF is wonderful. But what if we only posted that 50% of the time, and the other 50% we discussed legitimate concerns? Not concerns raised by obvious bashers and flippers like Solantey and such, but coming from legitimate longs.
I think Gerald and management need to hear from shareholders about their real concerns. The Shareholder Meeting would be a good place for voicing some of those honest concerns. Unlike Warp, I thought the gentleman who pressed Gerald on those 5 questions during the CC was right on!! Warp writes off discussion about concerns as anxious "hand wringing" and the cause of "sleepless nights" that only the poor engage in, who really shouldn't be invested in this type of stock in the first place. I thought the gentleman asking the questions on the CC was respectful, but earnest. Sending Gerald messages all the time about how much we all admire him is not what he really needs. He's the CEO managing our investment. He needs to hear from us. We need to discuss issues seriously...not just dream of how rich we'll be.
Gerald needs to know that his credibility is on the line over the way he has mismanaged expectations. At the Jan. Conference in SF he said we wouldn't be pursuing a LymPro partner in the immediate future because of the "codes" they found that had increased the Net Present Value of LymPro multiple times! We haven't really heard about those "codes" since and we are trading at less than we were in January when he announced it!
Several months after January Gerald stated they had "identified" a LymPro Partner which would be announced at the end of summer. I think most of us anticipated it would be a "classic partner" with up front money. So when he tweeted that Friday afternoon about how excited he was over the news the next week....it was a real shock that Monday morning when we got a "master service agreement" with ICON rather than a "Classic Partnership" with J&J with 40 million dollars up front!!! These two examples I've mentioned, along with the data debacle during the July Conferences are examples of how Gerald has not managed expectations or executed flawlessly. (Not that I want him replaced)
At the beginning of the year his goal was to up list in Q2 of 2014. Now we are hearing Q1 2015. People have criticized me for worrying too much about the short term pps. They think I need reminding that this is a long term investment. I get it. All I am saying is that until more shareholder value is created....management should no leverage our shares with a billion additional shares! There's no good reason for doing a billion shares now, not when we're trading at .10 cents in mid September.
To not discuss these concerns on this mb and not raise them with management, but simply let them double the AS shares without even a peep from us.....is nothing more than Kool Aid drinking insecurity!!
I hope as participants in this mb we can mature into something more. We are the owners of AMBS and we need to intelligently raise our voice to management on an ongoing basis, so that together we can realize the incredible potential AMBS has!
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼